Internal Medicine, Medical Oncology · New York, NY
NPI
1598936742
Since 2008
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1275 York Ave, Box 20
New York, NY, 10065
Phone (212) 639-2000
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
216 services
Medicare patients, 2024
58
Average age 72
Drug cost, 2024
$1.2M
356 prescriptions
Company payments, 2025
$3,402
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ping CHI was code 99215 (office e&m - established), 142 times for 47 patients. In total Ping CHI billed 216 services in 4 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 142 | 47 | $124.51 | $18K |
| 99214 Office E&M - Established | Office | 31 | 22 | $87.26 | $2,705 |
By year: 2022 $24K for 210 services; 2023 $28K for 242 services; 2024 $22K for 216 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ping CHI prescribed most often to Medicare patients was Imatinib Mesylate, with 234 prescriptions and refills. In total Ping CHI wrote 356 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Imatinib Mesylate Generic | 234 | 242 | 28 | $609K |
| Gleevec Imatinib Mesylate | 32 | 32 | Under 11 | $316K |
| Ondansetron Hcl Generic | 13 | 18 | Under 11 | $178 |
| Oxycodone Hcl Generic | 12 | 12 | Under 11 | $105 |
Brand drugs: 42 claims; generic drugs: 314 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ping CHI $3,402 ($3,402 in general payments such as food, travel and fees) from 3 companies. The largest payer was Deciphera Pharmaceuticals Inc. with $3,329.
| Company | Payments | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 8 | $3,329 |
| GlaxoSmithKline, LLC. GSK | 1 | $49.99 |
| bioMerieux Inc | 1 | $23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.